| Document |
Document Title |
|
WO/2020/220141A1 |
Transdermal cannabinoid formulations comprising a versatile cannabinoid stock provided as a variety of cosmetic delivery systems providing enhanced cannabinoid absorption, and more controlled release into vascular and/or lymphatic system...
|
|
WO/2020/217209A1 |
The invention provides a method for depolymerising a phenolic polymer, the method comprising reacting the phenolic polymer with dimethylsulphoxide (DMSO) and a hydrogen halide. The phenolic polymer may be selected from the group consisti...
|
|
WO/2020/214574A1 |
Herein are described apparatus and processes for the preparation of cannabinoids, such as cannabidiol (CBD) and derivatives thereof. The apparatus and processes described can be used for the one-step, flow-mediated synthesis of cannabidi...
|
|
WO/2020/215006A1 |
Provided herein are novel antibacterial compounds of Formula (I). The compounds can be made through enzymatic oxidative dimerization in the presence of a suitable organism and one or more metal salts. Pathogenic bacteria exposed to the c...
|
|
WO/2020/204161A1 |
The present invention provides a composition for promoting the secretion of extracellular vesicles. A composition for promoting the secretion of extracellular vesicles, the composition containing: a compound that has the structure of f...
|
|
WO/2020/198883A1 |
Transdermal medicaments containing cannabidiol (CBD) for use in the amelioration of conditions, including anxiety, depression, pain, inflammation, epilepsy, parkinson's disease, oxidative injury and nausea; and a method for preparing same.
|
|
WO/2020/196854A1 |
The present invention addresses the problem of providing: a composition for forming a resist underlayer film excellent in terms of etching resistance, heat resistance, flatness, and bending resistance; a resist underlayer film; a method ...
|
|
WO/2020/194237A1 |
Methods of rapidly inhibiting efflux from a cell, sensitizing a drug-resistant cell to a drug and treating a subject with a drug-resistant pathology, by administering tetrahydrocannabinolic acid (THCa), cannabidiol (CBD) or a combination...
|
|
WO/2020/189201A1 |
This method for producing bisphenol includes: a step for mixing an organic phase 1 that contains bisphenol, the organic phase 1 being in a mixed solution 1 of an aqueous phase 1 and the organic phase 1, with a chelating agent to obtain a...
|
|
WO/2020/184182A1 |
Provided is a bisphenol composition that has a bisphenol content of at least 95 mass% and contains at least 200 ppm by mass of a compound represented by general formula (II). Also provided is polycarbonate resin production method using t...
|
|
WO/2020/184183A1 |
Provided is a bisphenol composition that has a bisphenol content of at least 95 mass%, contains at least 150 ppm by mass of a bisphenol represented by general formula (II), and has a methanol solution color (Hazen Color Index) of not gre...
|
|
WO/2020/183370A1 |
Systems and methods for indicating an effect onset period of a cannabis product including an effect onset device having a timing mechanism to track the effect onset period. The effect onset device including a processor having an activati...
|
|
WO/2020/154811A9 |
An object of the present invention is to provide a compound for modulating expression of Major Histocompatibility Complex Class I (MHC-1) and/or TAP-1, in eukaryotic cells. In certain aspects, the compound is a curcuphenol, a terpene or ...
|
|
WO/2020/185661A1 |
The present invention provides a method of treating or mitigating seizures comprising compounds as described herein.
|
|
WO/2020/178053A1 |
Phenol derivatives of general formula (I) and (II), wherein meanings of the substituents are indicated in the description, their pharmaceutically acceptable salts, together with the processes for their preparation, their use as antimicro...
|
|
WO/2020/175495A1 |
Provided is a method for producing a salt by reacting M+X- with YH so as to generate XH and M+Y-, and then removing the generated XH so as to obtain M+Y-. M+X- is a salt of a cation represented by M+ and an anion represented by X-. M+Y- ...
|
|
WO/2020/168421A1 |
The invention provides cyclodextrin inclusion complexes of cannabis extracts, cannabinoids and cannabis terpenes, and methods of making such complexes. The cyclodextrin inclusion complexes include a host and guest compounds. The host may...
|
|
WO/2020/169135A1 |
The invention relates to a method for preparing cannabidiol and to an intermediate for preparing cannabidiol, wherein two intermediate are obtained, that is, a silylated olivetol and a silylated olivetol (2) and bromated olivetol (4) whi...
|
|
WO/2020/165902A1 |
The present invention provides methods of extraction of at least one cannabinoid from an initial cannabis biomass in "one-pot" step using toluene to form a toluene extract and using the toluene extract for producing high concentrations o...
|
|
WO/2020/165715A1 |
Methods and systems for generating a cannabis-based therapy including an inhalable cannabis derived compound are disclosed. The methods and systems include a patient portal and a server having a matching system stored there, on the match...
|
|
WO/2020/168155A1 |
A cocrystal of cannabidiol is disclosed, specifically a 1:1 cannabidiokL-pipecolic acid cocrystal The beneficial and therapeutic uses of the cocrystal and of compositions containing the cocrystal are also disclosed. The disclosure sets o...
|
|
WO/2020/162408A1 |
The present invention has the effect of making it possible to produce 1,1,1-trifluoro-2,2-bisarylethane efficiently by a simple procedure by condensing a mixture of fluoral and hydrogen fluoride with an aryl compound under anhydrous cond...
|
|
WO/2020/162876A1 |
Processes of producing cresols from a phenols containing feed are described. The processes involve a combination of dealkylation and transalkylation processes. The dealkylation process converts the heavy alkylphenols in an alkylphenols s...
|
|
WO/2020/160677A1 |
Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
|
|
WO/2020/160652A1 |
Described is a method of selectively isolating non-rigid structure meroterpenes (for example, cannabidiolic acid) from a complex matrix that may also contain rigid structure meroterpenes (for example, THCa), comprising selectively precip...
|
|
WO/2020/162877A1 |
Processes for making phenol and xylenes from a phenols-containing feed are described. The processes involve transalkylation of alkylphenols to form phenol and alkylbenzenes. The phenol is separated from the alkylbenzenes, and the alkylbe...
|
|
WO/2020/158931A1 |
The purpose of the present invention is to provide: a novel compound which is useful as a film forming material for lithography or as a material for forming an optical component; a resin which contains a constituent unit that is derived ...
|
|
WO/2020/155595A1 |
Disclosed are an aerobic oxidation system and a photocatalytic aerobic oxidation method therefor. The aerobic oxidation system comprises: 1) at least one of the following substances 1a) -1d): 1a) sulfinic acid or a derivative thereof; 1b...
|
|
WO/2020/159103A1 |
The present invention relates to a hydroquinone-resorcinol complex inclusion compound and a method for capturing or storing a low-molecular gas using same, and specifically, to a hydroquinone-resorcinol complex inclusion compound that ca...
|
|
WO/2020/136678A1 |
A PROCESS FOR PREPARATION OF TERTIARY BUTYL HYDROQUINONE The present invention relates to a process for preparation of tertiary butyl hydroquinone. More particularly, it relates to a process for preparation 5 of TBHQ by eradicating the c...
|
|
WO/2020/128767A1 |
The invention relates to compositions comprising water-soluble complexes of a-cyclodextrin (alpha-cyclodextrin) and cannabinoids and/or complexes of a-cyclodextrin and cannabis-derived terpenes, methods of making these a-cyclodextrin com...
|
|
WO/2020/130313A1 |
The present invention relates to a method for decomposing a phenolic by-product, and more particularly, to method for decomposing a phenolic by-product produced during a phenol production process, the method comprising the steps of: (S10...
|
|
WO/2020/124220A1 |
Provided are pharmaceutical compositions comprising cannabis such that when combusted produces cannabidiolic acid (CBDA) for inhalation. Also provided are pharmaceutical composition for inhalation by a subject comprising tetrahydrocannab...
|
|
WO/2020/124211A1 |
Press cake material is extracted with 80-100C water for up to 5 hours. The liquid is separated from the solid material, and the liquid is fermented/decarboxylated with suitable micro-organisms and/or suitable enzymes. The treated liquid ...
|
|
WO/2020/130314A1 |
The present invention relates to a method and an apparatus for decomposing a phenolic byproduct, the decomposing method comprising the steps of: (S10) supplying the phenolic byproduct to a reactive multistage distillation column; (S20) s...
|
|
WO/2020/124268A1 |
Methods for making oleosome-based cannabinoid formulations are disclosed herein. The methods include preparing and/or providing an oleosome suspension from a selected plant species, then combining the oleosome suspension with one or more...
|
|
WO/2020/119595A1 |
Provided are a phenol salt and application thereof as a catalyst in a hexavalent sulfur-fluoride exchange reaction, said phenol salt comprising cations and anions. The phenol salt is easy to synthesize and can be used as a catalyst for a...
|
|
WO/2020/123407A1 |
Some embodiments pertain to nanoparticle-based compositions and their use in methods for the delivery of CBD to subjects. In some embodiments, the compositions are stable for prolonged periods of time and provide enhanced bioavailability.
|
|
WO/2020/123365A1 |
Various aspects of this patent application relate to methods to separate a cannabinoid molecule from other molecules of a decarboxylated cannabinoid extract.
|
|
WO/2020/118415A1 |
Cannabis-based self-emulsifying products such as self-emulsifying capsules are described herein together with methods for preparing such self-emulsifying products. In at least some embodiments, a self-emulsifying drug delivery system is ...
|
|
WO/2020/114925A1 |
The invention relates to a method for producing a specific hydroxy compound by decarboxylating a specific carboxylic acid compound or a salt of said carboxylic acid compound in the presence of a Bronsted base. The invention also relates ...
|
|
WO/2020/114928A1 |
The invention relates to a process for preparing a specific hydroxy compound by means of decarboxylation of a specific carboxylic acid compound or a salt of said carboxylic acid compound, to a method for preparing a diaryl carbonate, a b...
|
|
WO/2020/116555A1 |
The present invention addresses the problem of providing: a liquid crystal composition which contains a polymerizable compound and which is used for producing a PSA type or PSVA type liquid crystal display element, wherein the speed of p...
|
|
WO/2020/114927A1 |
The invention relates to a method for producing a specific hydroxyl compound by decarboxylating a specific carboxylic acid compound or a salt of said carboxylic acid compound in the absence of a catalyst and to a method for producing a b...
|
|
WO/2020/115078A1 |
The present invention relates to new lightly colored prills of hydroquinone. More particularly, the invention provides a new method for preparing said lightly colored prills of hydroquinone. The invention also relates to said prills of h...
|
|
WO/2020/115936A1 |
The present invention addresses the problem of providing: a liquid crystal composition which contains a polymerizable compound for producing a PSA type or PSVA type liquid crystal display element that has a sufficient pretilt angle and e...
|
|
WO/2020/107114A1 |
Water-soluble formulations including cannabinoids or a cannabis-derived compound for use in beverages and foods, methods of preparing the formulations, and methods of preparing beverages and foods including the formulations are disclosed...
|
|
WO/2020/108989A1 |
The present inventions relates to the preparation of 3,3,5-trimethylcyclohexylidene bisphenol. Especially, the present invention relates to the preparation of 3,3,5- trimethylcyclohexylidene bisphenol from 3,3,5-trimethylcyclohexanone an...
|
|
WO/2020/107119A1 |
Cannabis and cannabis-derived compositions, methods of making and methods of using the compositions in oral dosage forms, such as in beverage forms, are disclosed herein. The compositions comprise a cannabinoid or a cannabis-derived comp...
|
|
WO/2020/109413A1 |
The instant invention concerns polymers obtained by radical copolymerization of a mixture of (1) acrylic acid; (2) methacrylic acid; and (3) at least one allylcatechol selected from 4-allylbenzene-1,2-diol, 3-allyl benzene-1,2-diol and m...
|
